Can a tiny implant tame glaucoma? a feasibility trial puts the VW-50 to the test

NCT ID NCT07730424

Completed Disease control Sponsor: Melbourne Eye Specialists Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This study tests a new device called the VW-50, a small implant designed to drain fluid from the eye and lower pressure in people with glaucoma. The trial will enroll 10 adults whose eye pressure remains high despite medication. Surgeons will implant the device and rate how easy it is to place, while researchers track safety and pressure changes over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a surgical implant called VW-50 that drains fluid from the eye to lower pressure
What this could lead to: If it works, this could offer a new surgical option for people with glaucoma whose eye pressure is not controlled by medication.
What could go wrong: This is a very early feasibility study with only 10 participants, so it is too small to prove safety or effectiveness. The implant is new and has not been tested in humans before.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA

Contacts and locations

Locations

Melbourne Eye Specialists

Fitzroy, Victoria, 3065, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.